🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05614193
Recruiting Observational

Deep Enhanced Imaging in Stroke and Vascular Neurology

NCT05614193 · tracked via the Priya Life Science China tracker
Sponsor
Chinese PLA General Hospital
Phase
Observational
Started
2022-12-01
Last updated
2023-02-08

Condition(s) studied

RadiologyCerebral StrokeVascular Diseases

Investigational drug(s) / intervention(s)

Deep learning imaging enhancement

Deep learning imaging enhancement: Conventional imaging or down-sampling imaging from CT or MR are enhanced by approved deep learning method.

Study summary

To investigate the performance of enhanced computed tomography (CT) or magnetic resonance (MR) imaging by deep learning relative to conventional CT or MR imaging in brain stroke and vascular neurology. We expect that the deep enhanced imaging method can shorten the time stay in the imaging session of stroke patients, optimize the overall imaging quality and improve the patients' care in imaging session.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * suspecting to have experienced stroke or cerebral ischemia and needed to undergo brain imaging and vascular imaging including CT or MRI * no history of kidney failure * a minimum age of 18 years * obtained written informed consent Exclusion Criteria: * severe movement artifacts * incidental finding of tumor lesion or craniocerebral surgery history * poor imaging failed to perform deep learning method * women who pregnancy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chinese PLA General Hospital Beijing Beijing Municipality Recruiting

More Chinese PLA General Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05614193 on ClinicalTrials.gov ↗ ← All trials in China